SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-20-000005
Filing Date
2020-08-12
Accepted
2020-08-12 09:07:33
Documents
83
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20200630.htm   iXBRL 10-Q 3580095
2 EX-31.1 formexhibit311.htm EX-31.1 9767
3 EX-31.2 formexhibit312.htm EX-31.2 9821
4 EX-32 formexhibit32.htm EX-32 6446
  Complete submission text file 0001802768-20-000005.txt   12871562

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20200630.xsd EX-101.SCH 77179
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20200630_cal.xml EX-101.CAL 118015
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20200630_def.xml EX-101.DEF 483002
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20200630_lab.xml EX-101.LAB 823083
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20200630_pre.xml EX-101.PRE 590296
10 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20200630_htm.xml XML 2421590
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 201094305
SIC: 2834 Pharmaceutical Preparations